Skip to main content
Research and analysis

Mpox: transmission, infectious and incubation periods

This rapid review identified and summarised evidence published before 15 August 2022 relating to mpox (monkeypox) (clade II) transmission, and mpox infectious and incubation periods.

Updates to this page

From:
UK Health Security Agency
Published:
2 March 2023
Last updated:
23 January 2025
Show all updates

  1. This review has been withdrawn.

  2. Moved 'Mpox: adherence and barriers to following isolation guidance: a rapid review' to separate page.

  3. First published.

This publication was withdrawn on

This rapid review has been withdrawn and superceded by:

The rapid review ‘Mpox: adherence and barriers to isolation’ is still available and has been published in a separate location.

Documents

[Withdrawn] Mpox: transmission, and infectious and incubation periods: a rapid review

Ref: GOV-14169

PDF, 1.47 MB, 31 pages

This file may not be suitable for users of assistive technology.

Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This rapid review identified and summarised the evidence relating to:

  • mpox (clade II) transmission
  • mpox infectious and incubation periods

The rapid review searched for research published up to 15 August 2022 and includes:

  • one review for pre-2022 outbreaks
  • 30 studies from 2022 on the transmission of mpox
  • no studies on mpox infectious periods
  • 8 studies on mpox incubation periods
  • 21 studies from 2022 for whether environmental or individual samples contained mpox DNA or live mpox virus

Sign up for emails or print this page

Related content